| __timestamp | Gilead Sciences, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 19764000 |
| Thursday, January 1, 2015 | 28633000000 | 67426000 |
| Friday, January 1, 2016 | 26129000000 | 59752000 |
| Sunday, January 1, 2017 | 21736000000 | 65383000 |
| Monday, January 1, 2018 | 17274000000 | 70165000 |
| Tuesday, January 1, 2019 | 17774000000 | 44738000 |
| Wednesday, January 1, 2020 | 20117000000 | 39457000 |
| Friday, January 1, 2021 | 20704000000 | 97894000 |
| Saturday, January 1, 2022 | 21624000000 | 115306000 |
| Sunday, January 1, 2023 | 20618000000 | 453552000 |
| Monday, January 1, 2024 | 78200000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, Gilead Sciences, Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories in gross profit from 2014 to 2023. Gilead Sciences, a titan in the biotech industry, consistently reported robust gross profits, peaking in 2015 with a remarkable 33% increase from the previous year. However, a gradual decline followed, with a 28% drop by 2018, before stabilizing around 2020. In contrast, HUTCHMED, a burgeoning player in the Chinese market, demonstrated a dynamic growth pattern. Starting with modest figures in 2014, HUTCHMED's gross profit surged by over 2,000% by 2023, reflecting its aggressive expansion and strategic market positioning. This decade-long analysis underscores the diverse strategies and market conditions influencing these two companies, offering valuable insights into their financial health and future prospects.
Key Insights on Gross Profit: AstraZeneca PLC vs Gilead Sciences, Inc.
Gross Profit Trends Compared: Amgen Inc. vs Gilead Sciences, Inc.
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or Alkermes plc
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Zoetis Inc. vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Grifols, S.A. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Comparison: Perrigo Company plc and HUTCHMED (China) Limited Trends
Gross Profit Comparison: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Trends